¼¼°è ³ú½Ç ¹è¾× ±â±â ½ÃÀå
Ventricular Drainage Devices
»óǰÄÚµå : 1536139
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2024³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 275 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,464,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 25,393,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

³ú½Ç ¹è¾× ±â±â ¼¼°è ½ÃÀåÀº 2030³â±îÁö 9¾ï 3,990¸¸ ´Þ·¯¿¡ À̸¦ Àü¸Á

2023³â¿¡ 5¾ï 9,420¸¸ ´Þ·¯·Î ÃßÁ¤µÇ´Â ³ú½Ç ¹è¾×±â±â ¼¼°è ½ÃÀåÀº 2030³â¿¡´Â 9¾ï 3,990¸¸ ´Þ·¯¿¡ À̸£°í, ºÐ¼® ±â°£ 2023-2030³â CAGRÀº 6.8%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ³ú½Ç ¹è¾× ½Ã½ºÅÛÀº CAGR 6.3%·Î ¼ºÀåÀ» Áö¼ÓÇϰí, ºÐ¼® ±â°£ Á¾·á ½Ã 3¾ï 7,710¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ³ú½Ç ¹è¾× ¾×¼¼¼­¸® ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 7.1%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 1¾ï 6,190¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 10.7%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ³ú½Ç ¹è¾×±â±â ½ÃÀåÀº 2023³â¿¡ 1¾ï 6,190¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2023-2030³â CAGRÀ» 10.7%·Î 2030³â±îÁö 2¾ï 350¸¸ ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ¸¸ÇÑ Áö¿ª ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 3.0%¿Í 6.7%·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 4.3%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ³ú½Ç ¹è¾× ±â±â ½ÃÀå - ÁÖ¿ä ÃËÁø¿äÀΰú µ¿Çâ ¿ä¾à

³ú½Ç ¹è¾× ±â±â´Â ¼öµÎÁõ, ¿Ü»ó¼º ³ú ¼Õ»ó, µÎ°³³» ÃâÇ÷°ú °°Àº Áõ»óÀ¸·Î ÀÎÇÑ µÎ°³ ³»¾ÐÀÇ »ó½ÂÀ» ¿ÏÈ­ÇÏ´Â µ¥ »ç¿ëµÇ´Â Áß¿äÇÑ ÀÇ·á±â±âÀÔ´Ï´Ù. ³ú½Ç¿Ü µå·¹ÀÎ(EVD) ¶Ç´Â ³ú½Ç Àý°³ ±â±â¶ó°íµµ ºÒ¸®´Â ÀÌ ±â±â´Â ³úô¼ö¾×(CSF)À» ¿ÜºÎ ¼öÁý ½Ã½ºÅÛÀ¸·Î ¿ìȸÇϱâ À§ÇØ ³ú½Ç ½Ã½ºÅÛ¿¡ »ðÀԵǴ īÅ×ÅÍ·Î ±¸¼ºµÇ¾î ÀÖ½À´Ï´Ù. ÀÌ ÀýÂ÷´Â µÎ°³ ³»¾ÐÀ» ¸ð´ÏÅ͸µÇÏ°í °ü¸®ÇÏ´Â µ¥ µµ¿òÀÌ µÇ¹Ç·Î ÀáÀçÀûÀÎ ³ú ¼Õ»óÀ» ¹æÁöÇϰí ȯÀÚ °á°ú¸¦ °³¼±ÇÕ´Ï´Ù. ³ú½Ç ¹è¾×´Â ³ú ½Å°æ ¼ö¼ú°ú Ä¡¸íÀûÀÎ °ü¸® ÇöÀå¿¡¼­ Áß¿äÇÑ °³ÀÔÀÌ¸ç ±Þ¼º ½Å°æ Áúȯ °ü¸®¿¡ Áß¿äÇÑ ¿ªÇÒÀ»ÇÕ´Ï´Ù.

³ú½Ç ¹è¾× ±â±âÀÇ µðÀÚÀΰú ±â´ÉÀº ¾ÈÀü¼º, Á¤È®¼º, »ç¿ë ÆíÀǼº Çâ»óÀ» ¸ñÇ¥·Î ÇÑ Áøº¸¸¦ µµÀÔÇϸ鼭 ÇØ¸¶´Ù Å©°Ô ÁøÈ­Çϰí ÀÖ½À´Ï´Ù. ÃֽŠEVD´Â °í±Þ ¾Ð·Â ¸ð´ÏÅ͸µ ½Ã½ºÅÛ°ú ÅëÇÕµÈ ¼ö¾× ȸ¼ö ±â±â¸¦ °®Ãß°í ÀÖÀ¸¸ç, µÎ°³ ³»¾ÐÀÇ ½Ç½Ã°£ ¸ð´ÏÅ͸µ°ú Á¤È®ÇÑ Á¦¾î¸¦ °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ³ú½Ç ¹è¾×¿Í °ü·ÃµÈ ÀϹÝÀûÀÎ ÇÕº´ÁõÀÎ °¨¿°ÀÇ À§ÇèÀ» ÁÙÀ̱â À§ÇØ Ç×±Õ Ä«Å×ÅÍ¿Í °°Àº Çõ½ÅÀûÀÎ ±â¼úÀÌ µµÀԵǾú½À´Ï´Ù. °Ô´Ù°¡ Á¶Àý °¡´ÉÇϰí ÇÁ·Î±×·¥ °¡´ÉÇÑ ¼ÇÆ®ÀÇ °³¹ßÀº °³º° ȯÀÚÀÇ Çʿ信 ¸Â°Ô ¼ö¾× ¹è¾×¸¦ ¼öÇàÇÏ´Â ´É·ÂÀ» °­È­ÇÏ¿© Ä¡·á È¿°ú¿Í ȯÀÚÀÇ ¾ÈÀü¼ºÀ» Çâ»ó½Ãŵ´Ï´Ù.

³ú½Ç ¹è¾× ±â±â ½ÃÀåÀÇ ¼ºÀåÀº ¸î °¡Áö ¿äÀο¡ ÀÇÇØ ¹ß»ýÇÕ´Ï´Ù. ù°, ½Å°æ Áúȯ ¹× ¿Ü»ó¼º ³ú ¼Õ»óÀÇ ¹ß»ý·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó È¿°úÀûÀÎ µÎ°³ ³»¾Ð °ü¸® ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. µÑ°, ½Å°æ ¿Ü°ú ±â¼ú°ú ÁßÁõ ȯÀÚ °ü¸®ÀÇ Áøº¸°¡ ³ú½Ç ¹è¾× ±â±âÀÇ ÀÀ¿ë ¹üÀ§¸¦ È®´ëÇÏ¿© ÀÓ»ó ÇöÀå¿¡¼­ÀÇ Ã¤¿ëÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. °Ô´Ù°¡ ¼öµÎÁõÀ̳ª ³úÁ¹Áß µîÀÇ Áúº´¿¡ °É¸®±â ½¬¿î ¼¼°è Àα¸ÀÇ °í·ÉÈ­°¡ ½ÃÀåÀÇ ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ƯÈ÷ ½ÅÈï ½ÃÀå¿¡¼­ ÇコÄɾî ÀÎÇÁ¶ó Áõ°¡¿Í ÷´Ü ÀÇ·á±â¼úÀÇ ÀÌ¿ëÀÌ °¡´ÉÇÏ°Ô µÈ °Íµµ ½ÃÀå È®´ë¿¡ Å« ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. °Ô´Ù°¡ ÀÇ·á±â±âÀÇ ¾ÈÀü¼º°ú ±â´É¼º Çâ»óÀ» ¸ñÇ¥·Î ÇÑ ¿¬±¸°³¹ßÀÇ Áö¼Ó°ú ÀÇ·á±â±â Á¦Á¶¾÷ü¿Í ÀÇ·á±â°üÀÇ Àü·«Àû Á¦ÈÞ°¡ Çõ½ÅÀûÀÎ Á¦Ç°ÀÇ µµÀÔÀ» °¡¼ÓÈ­Çϰí ÀÖ½À´Ï´Ù. ¸¶Áö¸·À¸·Î, µÎ°³ ³»¾ÐÀ» Àû½Ã¿¡ È¿°úÀûÀ¸·Î °ü¸®ÇÏ´Â Á߿伺¿¡ ´ëÇÑ °Ç°­ °ü¸® Àü¹®°¡¿Í ȯÀÚÀÇ ÀǽÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ³ú½Ç ¹è¾× ±â±â ¼ö¿ä¸¦ ²ø¾î ¿Ã¸®°í Ãֽгú ½Å°æ ¼ö¼ú°ú Áß¿äÇÑ Ä¡·á ÇöÀå¿¡¼­ ÇʼöÀûÀÎ µµ±¸·Î¼­ÀÇ ÁöÀ§¸¦ È®°íÈ÷ Çϰí ÀÖ½À´Ï´Ù.

Á¶»ç ´ë»ó ±â¾÷ ¿¹(Àü 86°Ç)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

JHS
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Ventricular Drainage Devices Market to Reach US$939.9 Million by 2030

The global market for Ventricular Drainage Devices estimated at US$594.2 Million in the year 2023, is expected to reach US$939.9 Million by 2030, growing at a CAGR of 6.8% over the analysis period 2023-2030. Ventricular Drainage Systems, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$377.1 Million by the end of the analysis period. Growth in the Ventricular Drainage Accessories segment is estimated at 7.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$161.9 Million While China is Forecast to Grow at 10.7% CAGR

The Ventricular Drainage Devices market in the U.S. is estimated at US$161.9 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$203.5 Million by the year 2030 trailing a CAGR of 10.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.0% and 6.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.

Global Ventricular Drainage Devices Market - Key Drivers and Trends Summarized

Ventricular drainage devices are critical medical instruments used to relieve elevated intracranial pressure caused by conditions such as hydrocephalus, traumatic brain injury, and intracranial hemorrhage. These devices, also known as external ventricular drains (EVDs) or ventriculostomy devices, consist of a catheter inserted into the brain's ventricular system to divert cerebrospinal fluid (CSF) to an external collection system. This procedure helps to monitor and manage intracranial pressure, thus preventing potential brain damage and improving patient outcomes. Ventricular drainage is a vital intervention in neurosurgical and critical care settings, playing a key role in the management of acute neurological conditions.

The design and functionality of ventricular drainage devices have evolved significantly over the years, incorporating advancements aimed at improving safety, accuracy, and ease of use. Modern EVDs are equipped with advanced pressure monitoring systems and integrated CSF collection units, allowing for real-time monitoring and precise control of intracranial pressure. Innovations such as antimicrobial catheters have been introduced to reduce the risk of infections, a common complication associated with ventricular drainage. Additionally, the development of adjustable and programmable shunts has enhanced the ability to tailor CSF drainage to individual patient needs, thereby improving therapeutic efficacy and patient safety.

The growth in the ventricular drainage devices market is driven by several factors. Firstly, the increasing incidence of neurological disorders and traumatic brain injuries has led to a higher demand for effective intracranial pressure management solutions. Secondly, advancements in neurosurgical techniques and critical care management have expanded the application of ventricular drainage devices, enhancing their adoption in clinical practice. Additionally, the aging global population, which is more susceptible to conditions such as hydrocephalus and stroke, has further fueled market growth. The rise in healthcare infrastructure and the availability of advanced medical technologies, particularly in emerging markets, have also played a significant role in market expansion. Moreover, ongoing research and development efforts aimed at improving device safety and functionality, along with strategic collaborations between medical device manufacturers and healthcare institutions, are accelerating the introduction of innovative products. Lastly, increased awareness among healthcare professionals and patients about the importance of timely and effective management of intracranial pressure has driven the demand for ventricular drainage devices, solidifying their position as essential tools in modern neurosurgical and critical care settings.

Select Competitors (Total 86 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â